Skip to search boxSkip to navigationSkip to main content

Gene expression profiling of Non-small cell lung cancer

  • Sunil Singhal(corresponding author)
    ,
  • ,
  • Suresh Ramalingam
    ,
  • Shi Yong Sun
*Corresponding author for this work
  • Emory University
Scholary Output:
Contribution to journal
Review article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Functional genomics has emerged over the past 10 years as a novel technology to study genetic alterations. Gene expression arrays are one genomic technique employed to discover changes in the DNA expression that occur in neoplastic transformation. Microarrays have been applied to investigating lung cancer. Specific applications include discovering novel genetic changes that occur in lung tumors. Microarrays can also be applied to improve diagnosis, staging and discover prognostic markers. The eventual goal of this technology is to discover new markers for therapy and to customize therapy based on an individual tumor genetic composition. In this review, we present the current state of gene expression array technology in its application to lung cancer.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 313-324 (12 pages)

Journal (Volume, Issue Number)

Lung Cancer (Volume 60, Issue 3)

Publication milestones

  • Published - 06/2008

Publication status

Published - 06/2008

ISSN

0169-5002

Publication IDs

  • Scopus: 44449164317
  • PubMed: 18440087

Publication metrics

Metrics

Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Captures
63
Citation count
52

Funding Details

This work was supported by funding from the Emory Center for Respiratory Health and Emory-GT Center for Cancer Nanotechnology Excellence. The authors would like to thank Dr. Steven M. Albelda and Dr. Charles Powell for their valuable input into preparation of this manuscript
FundersFunding number
Emory-GT Center for Cancer Nanotechnology Excellence
-
NCI
U54CA119338